Back to search

Article

Evaluation of MAOA Gene Polymorphism on the Efficacy of Antidepressant Treatment and Craving Severity for Betel-Quid Use Disorder

2024-08-02

Abstract excerpt

Betel quid (BQ) use disorder (BUD) is prevalent in many Asian countries, impacting approximately 600 million people. We conducted a randomized clinical trial to analyze the impact of MAOA genetic variations on the severity of BQ craving. This was measured using DSM-5 criteria and Yale-Brown Obsessive Compulsive Scale modified for betel-quid (Y-BOCS-BQ). Participants were grouped according to the severity of BUD an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df86d6c0-947f-5298-ba5e-5cb9de15d6b8
DOI
10.20944/preprints202408.0036.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of MAOA Gene Polymorphism on the Efficacy of Antidepressant Treatment and Craving Severity for Betel-Quid Use DisorderDOI 10.20944/preprints202408.0036.v1
Select a neighboring publication to make it the new centre.